Form 8-K - Current report:
SEC Accession No. 0001490978-24-000051
Filing Date
2024-06-18
Accepted
2024-06-18 16:19:19
Documents
13
Period of Report
2024-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-20240618.htm   iXBRL 8-K 72121
  Complete submission text file 0001490978-24-000051.txt   202805

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20240618.xsd EX-101.SCH 1913
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20240618_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20240618_pre.xml EX-101.PRE 13054
17 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20240618_htm.xml XML 3223
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 241052081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)